Jonathan M. Meyer, M.D.
Assistant Adjunct Professor of Psychiatry
SDVAMC
3350 La Jolla Villa Drive
San Diego, CA 92161
Phone #: 858 642-3570
FAX #: 858 642-6442
E-MAIL: jmmeyer@ucsd.edu

MIRECC Postgraduate Research Fellowship (MD or PhD)

Biography 
Dr. Meyer is a graduate of Stanford University and Harvard Medical School, and finished his adult psychiatry residency at Los Angeles County-USC Medical Center. At LA County-USC he subsequently completed fellowships in Consultation/Liaison Psychiatry and Psychopharmacology Research, and was on the faculty of USC and Oregon Health Sciences University before coming to UCSD. Dr. Meyer has published articles and chapters on various aspects of antipsychotic psychopharmacology, the pharmacokinetics of atypical antipsychotics, metabolic effects of atypical antipsychotics, and health outcomes in patients with schizophrenia. 

Research Focus 
One focus of research is extending the current knowledge about metabolic issues with antipsychotic therapy through prospective studies. The other primary area of research interest involves examining mechanisms to improve health care delivery for patients with schizophrenia and other chronic mental disorders. Website: Metabolic Research in Schizophrenia Laboratory

Selected Publications 

• Meyer JM, chief editor, Henry A Nasrallah co-editor. Medical Illness and Schizophrenia. American Psychiatric Press, Inc., Washington DC, 2003, 246 pp.
• Meyer JM, Prevalence of hepatitis A, hepatitis B and HIV among hepatitis C seroppositive state hospital patients: result from Oregon State Hospital. J Clin Psychiatry in press
• Meyer JM. Metabolic outcomes after one year: a retrospective comparison of weight, lipid and glucose changes between risperidone- and olanzapine-treated inpatients. Journal of Clinical Psychiatry 2002; 63(5): 425-33.
• Jin H., Meyer JM, Jeste DV. The phenomenology of new onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: an analysis of 45 published cases. Annals of Clinical Psychiatry 2002: 14(1): 59-64
• Meyer JM. Novel antipsychotics and severe hyperlipidemia. Journal of Clinical Psychopharmacology, 2001: 21(4): 369-74.